UCB News

@ucb_news

A global biopharma company focusing on creating value for people living with neurology and immunology diseases. We are inspired by patients, driven by science.

Headquarters, Brussels
Vrijeme pridruživanja: srpanj 2010.

Tweetovi

Blokirali ste korisnika/cu @ucb_news

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ucb_news

  1. prije 5 sati
    Poništi
  2. 29. sij

    Everything we do at UCB starts with one simple question: How will this create value for people now and into the future? That’s our raison d’être

    Poništi
  3. 28. sij
    Poništi
  4. proslijedio/la je Tweet
    23. sij

    It is all about collective and individual responsibility to really change our behavior. Isabelle Béraud of ⁦ at the

    Poništi
  5. 24. sij

    The drug development process can take 10-15 years from early-stage discovery to marketing authorization. has the potential to accelerate this process and make it significantly more efficient. Find out more

    Poništi
  6. 22. sij

    that women who experience a first fragility fracture are at significant risk for experiencing subsequent fractures, particularly in the 2 years after the fracture? Read a summary of the findings published in the Journal of Bone and Mineral Research

    Poništi
  7. proslijedio/la je Tweet

    Beim Pharma-Unternehmen in Monheim am Rhein tauschte sich mit einem spannenden Panel über die Bedeutung der für regionale Standortentwicklung & internationale Wettbewerbsfähigkeit aus.

    , , i još njih 2
    Poništi
  8. 10. sij

    Based on a recent UCB survey, almost 1 in 5 patients living with reported having to reduce their working hours, and one in 8 said the condition meant they had to give up work completely.

    Poništi
  9. 7. sij
    Poništi
  10. 30. pro 2019.

    We’re counting down to 2020 - not just a new day or a new year but a new decade! Stay tuned for news on the 2020’s promising innovations

    Poništi
  11. 23. pro 2019.

    It’s a special time of the year all over the world. We want to show our appreciation to everyone who has helped us delivering new solutions to patients

    Poništi
  12. 20. pro 2019.
    Poništi
  13. 20. pro 2019.

    There are approximately 5 million people living with rheumatoid arthritis in China, women are especially impacted. We are proud to support these patients by providing new treatment options. Learn more

    Poništi
  14. 18. pro 2019.
    Poništi
  15. 16. pro 2019.
    Poništi
  16. 12. pro 2019.
    Poništi
  17. 10. pro 2019.

    Can help with early diagnosis of vertebral ? What do you think ?

    Poništi
  18. 10. pro 2019.

    is forecast to affect 12.9 million people by 2040. Read how could accelerate the development of new therapeutic options for people living with PD

    Poništi
  19. 10. pro 2019.
    Poništi
  20. 10. pro 2019.

    At this year’s , we’re proud to announce our new which helps diagnose and grade vertebral using . Find out more here:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·